Although associations between spatial/scene processing and genetic risk for AD (such as APOE ɛ4 dosage [22]) have been documented, working toward a larger polygenic model will provide more power for assessing the broader relationship between genes that confer risk and brain function. This evidence concerns the gene APOE and Alzheimer disease.